Intervention program for individuals who attempted suicide
Attempted Suicide Intervention Treatment and Prevention: a Randomised Controlled Trial
NA · Hospital Universitari Vall d'Hebron Research Institute · NCT06238414
This study tests whether early psychological treatment helps people who have been hospitalized after a serious suicide attempt recover better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute (other) |
| Locations | 1 site (Barcelona) |
| Trial ID | NCT06238414 on ClinicalTrials.gov |
What this trial studies
This program aims to evaluate the effectiveness of early individual psychological treatment for patients hospitalized after a medically serious suicide attempt (MSSA). It focuses on those who have been hospitalized for 24 hours or more and examines the impact of psychotherapeutic interventions on their recovery. The study will also analyze trends in MSSA incidence during the COVID-19 pandemic and assess various biological, psychosocial, and clinical variables related to the intervention. A randomized controlled trial will be conducted at two general hospitals in Barcelona.
Who should consider this trial
Good fit: Ideal candidates are individuals over 16 years old who have been hospitalized for 24 hours or more following a medically serious suicide attempt.
Not a fit: Patients who were discharged in less than 24 hours or those with cognitive impairments may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the risk of re-attempting suicide and improve the overall quality of life for patients.
How similar studies have performed: Other studies have shown promise in early psychotherapeutic interventions for suicide prevention, but this specific approach focusing on MSSA is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Older than 16 years. * Remaining hospitalized for 24 hours or more at HUVH and HCP after a MSSA for 24 or more (\> = 24 hours). * Needing specialized care units (including Intensive Care Units, Hyperbaric Camera Units, Burned Units, Semicritical Units) * Needing specialized surgical treatment, excluding superficial cuts * Needing extensive medical treatment and observation (gastric lavage, activated charcoal, observation of neurological tests or other complementary tests) * MSSA with high lethality methods (precipitation, hanging, firearm, stabbing) needing hospitalization for 24 or more hours, regardless of the treatment unit. Exclusion Criteria: * Patients with suicide attempts who were discharged in \<24 h * Patients under 16 years. * Patients with mild to severe cognitive impairment. * Lack of informed consent.
Where this trial is running
Barcelona
- Anna Beneria — Barcelona, Spain (RECRUITING)
Study contacts
- Principal investigator: Maria Dolores Braquehais — VHIR
- Study coordinator: Anna Beneria Gonzàlez
- Email: anna.beneria@vallhebron.cat
- Phone: +34932746087
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Suicide, Attempted, Suicide Prevention, Medically serious suicide attempts, Psychotherapy, Intervention, Randomized controlled trial